Learn More


 
MBA Tools
MBA Glossary

 


Rigel Pharmaceuticals, Inc. - RIGL - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

Rigel Pharmaceuticals, Inc. - SIC # 2834

Ticker Exchange SIC # Website Latest Ticker
RIGL Nasdaq 2834 http://www.rigel.com/indexnoflash.php 4.74 Stock Down -0.11

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Rigel Pharmaceuticals, Inc.

RIGEL PHARMACEUTICALS INC Financials - May 14th, 2013 11:04 am
3 Drug Catalysts to Watch in 2013 - May 9th, 2013 2:29 pm
April's Unhealthiest Stocks - May 4th, 2013 6:00 am
3 Biggest Biotech Crashes in April - May 1st, 2013 10:19 pm
5 Stocks Poised for Breakouts - Apr 12th, 2013 11:32 am
AZN Reports Data on Fostamatinib - Apr 8th, 2013 4:05 pm
Why Rigel Is Poised to Bounce Back - Apr 8th, 2013 7:47 am
This Week in Biotech - Apr 6th, 2013 10:30 am


View All Current Headlines >>

Bookmark and Share
facebooktwitter